Snowball logo
logo
EXTX

Exact Therapeutics AS

NOK 0.70NOK 0.00  (0%)
Estimate
EPS
-0.93
Beta
0.109
About the company
Ticker
EXTX
ISIN
NO0010852213
Country
Norway
Sector (GICS)
Healthcare
EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a novel ultrasound-mediated technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT) in Norway. The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various applications, including oncology, neurological conditions, and gene therapy. The company's ACT platform is under Phase 2 clinical trial for the treatment of pancreatic disease; Phase I clinical trial for treatment of liver metastases; and pre-clinical studies for glioblastoma, and immunotherapy diseases, as well as CNS diseases and gene therapy. It has a collaboration with GE Healthcare. The company was formerly known as Phoenix Solutions AS. EXACT Therapeutics AS was founded in 2012 and is based in Oslo, Norway.

Frequently asked questions

What sector does Exact Therapeutics AS (EXTX) operate in?

Exact Therapeutics AS belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Exact Therapeutics AS (EXTX) current stock price?

As of the latest data, Exact Therapeutics AS stock price is NOK 0.70, with a previous close of NOK 0.70.

What is Exact Therapeutics AS (EXTX) current market capitalization?

Exact Therapeutics AS market cap is approximately 78.08 million.

What is Exact Therapeutics AS (EXTX) Earnings Per Share (EPS)?

The trailing EPS is -NOK 0.93.

Does Exact Therapeutics AS (EXTX) pay dividends?

No. Exact Therapeutics AS does not pay a dividend.

What is Exact Therapeutics AS (EXTX) beta (volatility) score?

Exact Therapeutics AS has a beta of 0.109, indicating lower volatility than the overall market.